Today, in a world where we are often judged by facial appearance, aesthetic and reconstructive dentistry offers the opportunity to transform lives. The CMP clinic provides comprehensive multi-disciplinary treatment planning to create the most aesthetically pleasing, functional and long-lasting smile. Most of our services include: conventional porcelain fused to metal crowns and bridges, restoration of dental implants with crowns and fixed prosthesis.
|Fig 1||Fig 2|
|Fig 3||Fig 4|
An obturator prosthesis is a removable intraoral device that is frequently used in cases of maxillary resection resulting in an oral, nasal, sinus cavity communication, decreased palatal support, and partial loss of the maxilla. Such devices can be designed as a combination of implant retained and tissue supported restoration. An advantage of the obturator prosthesis is that it is noninvasive in nature and allows for clinical re-evaluation and possible early detection of disease recurrence.
|Fig 5||Fig 6|
|Fig 7||Fig 8|
All on Four
Complete edentulous jaws are much more of a widespread handicap than most of us realize. One out of every four Americans over 60 years of age has failing or “terminal” dentition and is becoming edentulous. Traditionally, complete dentures have been the treatment of choice for the edentulous patient. Today dental treatment has advanced with the use of dental implants. Dental implants significantly improve retention and stability to such a level that the prosthesis can be completely fixed to the jaw depending on the number and location of implants.
The "All on Four” concept is an implant retained full restoration that offers a viable and cost effective implant based solution that produces immediate function and satisfaction. The concept starts with the team approach where our surgeon, prosthodontist, and dental laboratory technician work together. Treatment planning utilizes advanced digital technology to formulate a plan that fits each patient’s unique anatomy. Implants are placed by the oral maxillofacial surgeon according to the plan. The prosthetic teeth that have been prefabricated by the on-site technician are modified and placed by the restorative dentist immediately following surgery. Such prosthetic designs should be understood as a “restorative chain” where the main components are: bone, implants, abutments, screws, and prosthetic teeth. With a screw retained implant system, the team is able to have easy access when providing follow up care on your prosthesis. Reducing the number of implants needed to properly retain a dental prosthesis makes treatment inheritably more affordable. Through the use of advanced technology and a team approach we strive to offer our patients improved cosmetic and functional outcomes and a better quality of life in a predictable manner. Over 10 years of predictable results makes our team a true leader in the dental community.
|Fig 9||Fig 10||Fig 11|
“Avulsive injuries and ablative surgery for aggressive disease may leave anatomy that provides no effective means of stabilizing a dental prosthesis”. These surgical consequences are not negligible and depend on lesion location and size, significant structural loss can occur in the maxilla or the mandible. Such defects interfere with major oral functions such as mastication, deglutition, and speech, and lead to facial deformities that can hinder the patient’s return to normal social life.
|Fig 12||Fig 13|
|Fig 14||Fig 15|
Bone Graft Augmentation
Correction of bony defects can be predictably augmented with the use of free bone grafts, these grafted defects then produce increased stability and support for the prosthetic restoration.
|Fig 17||Fig 18|
|Fig 19||Fig 20|
Recombinant Human Bone Morphogenetic Proteins
Bone morphogenetic proteins (BMPs) are a group of osteoinductive, sequentially arranged amino acids and polypeptides that are capable of stimulating cells to become osteoblastic and form bone.
Recent human studies of maxillary sinus floor grafting have demonstrated the ability of rhBMP-2, delivered on an absorbable collagen sponge (ACS), to induce new bone formation in the sinus without adverse sequelae. In March, 2007, the Food and Drug Administration approved the use of rhBMP-2 "as an alternative to autogenous bone graft for sinus augmentations, and for localized alveolar ridge defects associated with extraction sockets." The data from the initial studies demonstrated that the rhBMP-2/ACS placed in maxillary sinuses produced new bone that was capable of supporting dental implants. Tissue engineered osteoinductive grafts may someday eliminate the need for harvesting corticococancellous grafts.
|Fig 21||Fig 22|
|Fig 23||Fig 24|